A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

ON THIS PAGEDigestive Problems'Ozempic Face'Oral Hygiene ChangesHair LossWomen's HealthSee more (11) Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for ...

Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for weight loss in a head-to-head trial with semaglutide (Ozempic, Wegovy).

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Conducted by Weill Cornell Medicine, the study revealed that tirzepatide outperforms semaglutide in terms of weight loss and waist circumference reduction.

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision to declare the end of the shortage of Novo Nordisk’s semaglutide, Judge ...

Erectile dysfunction affects over 40% of men over 40, yet our understanding of the condition remains limited. Research on this issue has mostly relied on real organs, making it difficult to study ...

What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).

Researchers conducted a three-year-long study that involved about 500,000 men aged 40 and up and found health improvements in men who took drugs for erectile dysfunction.